Network origin in Helen Redmond first degree
Entity | Entity type | Industry | |
---|---|---|---|
Public Company | Miscellaneous Commercial Services | 6 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Helen Redmond via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
ELI LILLY AND COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
ASTRAZENECA PLC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Rochester Christian University | College/University | Undergraduate Degree | |
HVIVO PLC | Miscellaneous Commercial Services | Director/Board Member | |
University of Virginia | College/University | Doctorate Degree | |
EVOTEC SE | Pharmaceuticals: Major | Director/Board Member | |
ACTIVE BIOTECH AB | Biotechnology | Director/Board Member | |
Novo Holdings AS (Denmark)
Novo Holdings AS (Denmark) Financial ConglomeratesFinance Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation?s assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark. | Financial Conglomerates | Corporate Officer/Principal | |
University of Oxford | College/University | Doctorate Degree | |
University of Glasgow | College/University | Undergraduate Degree | |
University of Cambridge | College/University | Undergraduate Degree | |
Smith System Engineering Ltd
Smith System Engineering Ltd Miscellaneous Commercial ServicesCommercial Services Part of Smith System Engineering Ltd. /1994 Fund/, Smith System Engineering provides engineering consulting services. The company is based in Guildford, UK. The British company was founded by Bruce Gordon Smith. Smith System Engineering was acquired by Smith System Engineering. /1994 Fund/ on June 01, 1997 for $19.59 million. | Miscellaneous Commercial Services | Founder | |
The University of Edinburgh | College/University | Doctorate Degree | |
University of Vienna | College/University | Graduate Degree | |
LEO Pharma A/S
LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Corporate Officer/Principal | |
ZEALAND PHARMA A/S | Pharmaceuticals: Major | Director/Board Member | |
The Open University | College/University | Masters Business Admin | |
The UK Innovation & Science Seed Fund LP
The UK Innovation & Science Seed Fund LP Investment ManagersFinance The UK Innovation & Science Seed Fund LP, an evergreen fund, invests in seed-stage companies located in the United Kingdom. It targets companies operating in biotechnology, synthetic biology, engineering, agriculture, computer science, and environmental technology sectors. It provides equity financing for seed to early-stage transactions. | Investment Managers | Chairman | |
Touchstone Innovations Investment Management Ltd.
Touchstone Innovations Investment Management Ltd. Investment ManagersFinance Touchstone Innovations Investment Management Ltd. is a Venture Capital firm, a subsidiary of Touchstone Innovations Ltd. founded in 1986. Touchstone Innovations Investment Management Ltd. is headquartered in London. | Investment Managers | Director/Board Member | |
Imagineer Systems Ltd.
Imagineer Systems Ltd. Movies/EntertainmentConsumer Services Imagineer Systems Ltd. develops and markets visual effects solutions. Its products include mocha Pro, mocha Plus, Boris FX and training products. The company was founded by Allan Jaenicke and Philip F. McLauchlan in June 2000 and is headquartered in Guildford, the United Kingdom. | Movies/Entertainment | Director/Board Member | |
MIRRIAD ADVERTISING PLC | Advertising/Marketing Services | Director/Board Member | |
NYKODE THERAPEUTICS | Pharmaceuticals: Major | Director/Board Member | |
Novo Seeds
Novo Seeds Investment ManagersFinance Novo Seeds (Novo Seeds) is a venture capital operating division of Novo Nordisk Fonden. The firm was established in 2007, and is headquartered in Hellerup, Denmark. | Investment Managers | Corporate Officer/Principal | |
Bellcomm, Inc. | Corporate Officer/Principal | ||
ORPHAZYME A/S | Pharmaceuticals: Major | Corporate Officer/Principal | |
Caerus Consulting AS
Caerus Consulting AS Pharmaceuticals: MajorHealth Technology Caerus Consulting AS engages in the research and development in biotechnology. It develops antibiotics for life threatening bacterial diseases. Its technological core is chemistry on complex molecules. The company was founded by Torgeir Vaage on March 31, 2009 and is headquartered in Hovik, Norway. | Pharmaceuticals: Major | Director/Board Member | |
British Antarctic Survey
British Antarctic Survey Miscellaneous Commercial ServicesCommercial Services British Antarctic Survey delivers and enables interdisciplinary research in the Polar Regions. The company is headquartered in Cambridge, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
Contera Pharma ApS
Contera Pharma ApS Pharmaceuticals: MajorHealth Technology Contera Pharma ApS is a holding company that identifies and develops treatments for patients suffering from movement disorders. It develops drug candidates based on a combination of repositioning, combinations, and reformulations. The firm's lead project JM-010 is for treatment of dyskinesia associated with Parkinson's disease. It develops an approach of using a combination therapy to tackle clinically relevant synergistic pathways to obtain therapeutic effects which will generate efficacious therapeutic entities based on robust pre-clinical and clinical evidence. The company was founded by Mikael Søndergaard Thomsen and John Bondo Hansen in 2010 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Director/Board Member | |
Autifony Therapeutics Ltd.
Autifony Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Autifony Therapeutics Ltd. discovers and develops new pharmaceutical treatments treat hearing disorders. The firm focuses on the treatment of hearing disorders, including noise-induced hearing loss and tinnitus. The company was founded by Charles H. Large and Giuseppe S. Alvaro in 2011 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
MISSION Therapeutics Ltd.
MISSION Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology MISSION Therapeutics Ltd. develops small molecule drugs targeting enzymes involved in cancer and other diseases. It focuses on selectively targeting deubiquitylating enzymes to treat cancer, neurodegenerative and other diseases. The company was founded by Stephen Jackson Philip, Xavier Jacq, Niall M. B. Martin and Keith Menear in 2011 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Acesion Pharma ApS
Acesion Pharma ApS Pharmaceuticals: MajorHealth Technology Acesion Pharma ApS develops drugs for the treatment of atrial fibrillation (AF), the most common type of cardiac arrhythmia. The firm's technology blocks ion channel with a selective drug molecule constitutes a target for developing treatment of AF. The company was founded by Ulrik Svane S?rensen and Morten Grunnet in 2011 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Director/Board Member | |
IP Group Plc /Venture Capital/
IP Group Plc /Venture Capital/ Investment ManagersFinance IP Group Plc /Venture Capital/ (IP Group) is a venture capital subsidiary of IP Group Plc founded in 2001. The firm is headquartered in London, United Kingdom. | Investment Managers | Director/Board Member | |
Institut d'Administration Des Entreprises De Toulouse | College/University | Undergraduate Degree | |
Avilex Pharma ApS
Avilex Pharma ApS Pharmaceuticals: MajorHealth Technology Avilex Pharma ApS develops and produces drugs to treat brain damage with the uses of dimeric ligands. It also develops novel inhibitors to target a range of unmet medical needs. The firm uses dimeric ligands that targets intracellular with unprecedented potency. The company was founded by Kristian Strømgaard and Anders Bach on December 27, 2012 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Chairman | |
Pulmocide Ltd.
Pulmocide Ltd. Pharmaceuticals: MajorHealth Technology Pulmocide Ltd. provides biopharmaceutical services. It develops inhaled medicines for viral and fungal infections of the respiratory tract. The company was founded by William Garth Rapeport, John Murray, Kazuhiro Ito, and Peter Strong on March 23, 2007 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Maxygen ApS | Corporate Officer/Principal | ||
Enterprise Therapeutics Ltd.
Enterprise Therapeutics Ltd. BiotechnologyHealth Technology Enterprise Therapeutics Ltd. operates as a drug discovery company that engages in the research and development of therapies for the treatment of respiratory diseases. It focuses on developing therapies for chronic obstructive pulmonary diseases, cystic fibrosis, and asthma. The company was founded by John Mervyn David Store in May 2014 and is headquartered in Falmer, the United Kingdom. | Biotechnology | Director/Board Member | |
Carrick Therapeutics Ltd.
Carrick Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Carrick Therapeutics Ltd. manufactures cancer therapeutics. The company is headquartered in Dublin, Ireland. | Pharmaceuticals: Major | Chief Executive Officer | |
Oxular Ltd.
Oxular Ltd. BiotechnologyHealth Technology Oxular Ltd. engages in research and experimental development on biotechnology. The firm develops retinal treatments to access specific small spaces in the eye and to provide drug distribution to tissues involved in retinal diseases. The company was founded by Tom Cavanagh and Ronald K. Yamamoto in 2014 and is headquartered in Oxford, the United Kingdom. | Biotechnology | Director/Board Member | |
STORM Therapeutics Ltd.
STORM Therapeutics Ltd. BiotechnologyHealth Technology Storm Therapeutics Ltd. develops small molecule drugs that target RNA-modifying enzymes. It offers research and development of drug molecules for the treatment of specific cancers. The company was founded by Anthony Kouzarides and Eric Miska on April 21, 2015 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Director/Board Member | |
Artios Pharma Ltd.
Artios Pharma Ltd. Pharmaceuticals: MajorHealth Technology Artios Pharma Ltd. manufactures pharmaceutical products. The firm develops a DNA Damage Response (DDR) is a cancer therapy. The company was founded by Niall Martin in May 2016 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
HVIVO PLC | Miscellaneous Commercial Services | Director/Board Member | |
Curadh Pharmaceuticals Ltd. | Chief Executive Officer | ||
Keltic Pharma Therapeutics Ltd.
Keltic Pharma Therapeutics Ltd. BiotechnologyHealth Technology Keltic Pharma Therapeutics Ltd. is an Irish private company. The firm engages in drug discovery programs. | Biotechnology | Chief Executive Officer | |
Smith Institute
Smith Institute Miscellaneous Commercial ServicesCommercial Services The Smith Institute provides mathematical consultancy services for industry, business, and government industry. It specializes in mathematical models, algorithm design, data analysis, software, system validation, and optimization. The company was founded by Bruce Gordon Smith in 1997 and is headquartered in Guildford, the United Kingdom. | Miscellaneous Commercial Services | Founder |
Statistics
International
United Kingdom | 26 |
Denmark | 12 |
United States | 5 |
Norway | 3 |
Ireland | 3 |
Sectoral
Health Technology | 25 |
Consumer Services | 11 |
Commercial Services | 7 |
Finance | 6 |
Operational
Director/Board Member | 25 |
Corporate Officer/Principal | 7 |
Chairman | 5 |
Undergraduate Degree | 5 |
Founder | 4 |
Most connected contacts
Insiders | |
---|---|
Bobby G. Soni | 23 |
Elaine Sullivan | 15 |
Bruce Gordon Smith | 9 |
Gerlinde Boback | 3 |
Chris Glasson | 3 |
Catherine Shennan | 1 |
- Stock Market
- Insiders
- Helen Redmond
- Company connections